Our Background

Excellence built from a unique heritage

Today, Beactica is heralded by its collaborators and partners as the leader in fragment-based drug discovery using SPR biosensor technology. This position has its roots in a unique heritage spanning decades of research and industrial development: 

This unique heritage – in combination with the team's dedication to scientific excellence – has enabled Beactica to develop its proprietary platform to efficiently identify and develop novel and mechanistically defined drug leads. Read more about the platform here.

Stay Updated

Sign up for the Beactica newsletter to receive our latest news and updates

This website uses cookies to improve your user experience. By continuing to browse this site, you agree to our use of cookies. More information. Ok!